Bachem Holding AG
SIX:BANB

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
SIX:BANB
Watchlist
Price: 80.25 CHF 1.52% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Bachem Holding AG?
Write Note

Profitability Summary

Bachem Holding AG's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Bachem Holding AG

Revenue
577.3m CHF
Cost of Revenue
-400.4m CHF
Gross Profit
177m CHF
Operating Expenses
-47.6m CHF
Operating Income
129.4m CHF
Other Expenses
-17.5m CHF
Net Income
111.9m CHF

Margins Comparison
Bachem Holding AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CH
Bachem Holding AG
SIX:BANB
6B CHF
31%
22%
19%
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
55%
14%
6%
US
Thermo Fisher Scientific Inc
NYSE:TMO
228.2B USD
41%
18%
15%
US
Danaher Corp
NYSE:DHR
192.7B USD
59%
21%
19%
KR
Samsung Biologics Co Ltd
KRX:207940
66.3T KRW
48%
29%
23%
CH
Lonza Group AG
SIX:LONN
39.8B CHF
36%
20%
10%
US
IQVIA Holdings Inc
NYSE:IQV
43.3B USD
35%
14%
9%
US
Agilent Technologies Inc
NYSE:A
39.8B USD
51%
20%
19%
US
Mettler-Toledo International Inc
NYSE:MTD
30B USD
59%
28%
21%
IE
ICON PLC
NASDAQ:ICLR
26.2B USD
30%
13%
8%
US
West Pharmaceutical Services Inc
NYSE:WST
21.3B USD
36%
21%
18%
Country CH
Market Cap 6B CHF
Gross Margin
31%
Operating Margin
22%
Net Margin
19%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Operating Margin
14%
Net Margin
6%
Country US
Market Cap 228.2B USD
Gross Margin
41%
Operating Margin
18%
Net Margin
15%
Country US
Market Cap 192.7B USD
Gross Margin
59%
Operating Margin
21%
Net Margin
19%
Country KR
Market Cap 66.3T KRW
Gross Margin
48%
Operating Margin
29%
Net Margin
23%
Country CH
Market Cap 39.8B CHF
Gross Margin
36%
Operating Margin
20%
Net Margin
10%
Country US
Market Cap 43.3B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 39.8B USD
Gross Margin
51%
Operating Margin
20%
Net Margin
19%
Country US
Market Cap 30B USD
Gross Margin
59%
Operating Margin
28%
Net Margin
21%
Country IE
Market Cap 26.2B USD
Gross Margin
30%
Operating Margin
13%
Net Margin
8%
Country US
Market Cap 21.3B USD
Gross Margin
36%
Operating Margin
21%
Net Margin
18%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Bachem Holding AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
Bachem Holding AG
SIX:BANB
6B CHF
9%
7%
9%
10%
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
2%
1%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
228.2B USD
14%
6%
9%
8%
US
Danaher Corp
NYSE:DHR
192.7B USD
8%
5%
6%
5%
KR
Samsung Biologics Co Ltd
KRX:207940
66.3T KRW
9%
5%
9%
6%
CH
Lonza Group AG
SIX:LONN
39.8B CHF
7%
4%
9%
8%
US
IQVIA Holdings Inc
NYSE:IQV
43.3B USD
23%
5%
11%
9%
US
Agilent Technologies Inc
NYSE:A
39.8B USD
21%
11%
14%
14%
US
Mettler-Toledo International Inc
NYSE:MTD
30B USD
-648%
24%
49%
29%
IE
ICON PLC
NASDAQ:ICLR
26.2B USD
8%
4%
8%
6%
US
West Pharmaceutical Services Inc
NYSE:WST
21.3B USD
20%
15%
20%
18%
Country CH
Market Cap 6B CHF
ROE
9%
ROA
7%
ROCE
9%
ROIC
10%
Country US
Market Cap 1.3T USD
ROE
2%
ROA
1%
ROCE
3%
ROIC
3%
Country US
Market Cap 228.2B USD
ROE
14%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 192.7B USD
ROE
8%
ROA
5%
ROCE
6%
ROIC
5%
Country KR
Market Cap 66.3T KRW
ROE
9%
ROA
5%
ROCE
9%
ROIC
6%
Country CH
Market Cap 39.8B CHF
ROE
7%
ROA
4%
ROCE
9%
ROIC
8%
Country US
Market Cap 43.3B USD
ROE
23%
ROA
5%
ROCE
11%
ROIC
9%
Country US
Market Cap 39.8B USD
ROE
21%
ROA
11%
ROCE
14%
ROIC
14%
Country US
Market Cap 30B USD
ROE
-648%
ROA
24%
ROCE
49%
ROIC
29%
Country IE
Market Cap 26.2B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 21.3B USD
ROE
20%
ROA
15%
ROCE
20%
ROIC
18%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top